US Import Tariffs: With 25% Threat, Indian Industry Reads Between Trump Lines

About Half Of Generics Supply From India

 
• By Vibha Ravi
  
Trump's Threat Of US Import Tariffs Looms Large On The Pharma Landscape
Trump's Threat Of US Import Tariffs Looms Large On The Pharma Landscape

More from India

More from Focus On Asia